Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 9 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Company News For May 13, 2024
Zacks via Yahoo Finance· 13 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 19 hours agoHe did not provide specific timing but emphasized these are strategic...some light on the branding message and the future commercialization of Sanofi and Novavax branded products ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 15 hours agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing ...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 4 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 4 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoA Phase 3 study is already underway with the initial results expected later this decade. But at...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...